Proven Connect Logo
Stratosvir Limited
Targeting tumours with a new method of drug delivery
Investment Overview
Target:
Minimum: Currently seeking a raise of £600,000
Stage: Seed investment
Minimum: Currently seeking a raise of £600,000

Share this

Targeting tumours with a new method of drug delivery

Investment Details

Therapeutic viruses have huge potential yet cannot currently be delivered intravenously, being limited to intratumoral injection. This restricts their clinical use.

Stratosvir Limited are developing a pioneering platform which is designed to relieve this crucial barrier that prevents systemic delivery. This allows their cancer-killing virus to deliver medicinal payloads within the tumour to stimulate and reprogram the immune system to attack and destroy cancer.

 

Investment Highlights
Funded by Deep Science Ventures, its partners and CRUK, Stratosvir has assembled significant expertise in virology, immunology, oncology and molecular engineering to guide its mission.